GlaxoSmithKline
FTSE 100 bosses ‘given average pay rise of £500,000 in 2022’
CEOs received average increase of 16% while pay of many working for them failed to keep up with inflation
Rupert Neate Wealth correspondent
22, Aug, 2023 @4:00 AM
RSV vaccine for older adults approved by UK medicines regulator
Arexvy could help NHS deal with virus that causes about 8,000 deaths among older people in UK each year
Linda Geddes Science correspondent
10, Jul, 2023 @3:22 PM
‘Gamechanging’ TB vaccine within reach after $500m pledge to run final trials
Joint deal between Gates Foundation and Wellcome to develop M72 jab could save 8.5 million lives and prevent 76 million cases
Sarah Boseley
28, Jun, 2023 @5:14 PM
New CBI boss says she is ‘profoundly sorry’ to women let down by group
Rain Newton-Smith’s tweets came on day she became director general at Confederation of British Industry
Julia Kollewe and Anna Isaac
26, Apr, 2023 @4:39 PM
AstraZeneca overtakes Pfizer as crunch week for UK pharma looms
Driven by a revamped drug portfolio, AstraZeneca is expected to report revenues of $10.7bn in its latest quarterly results
Julia Kollewe
24, Apr, 2023 @6:06 AM
Take AstraZeneca’s warning seriously. The UK is missing out in life sciences
Big pharma has choices about where to make new investments and, increasingly it seems, it is not choosing Britain
Nils Pratley
09, Feb, 2023 @6:33 PM
GSK boss warns UK life sciences at ‘tipping point’ despite Sunak’s R&D pledge
Emma Walmsley says ambition to be pharma superpower at risk unless improvements made in key areas
Julia Kollewe
01, Feb, 2023 @5:08 PM
Moonpig flotation price, like so many, was always pie-in-the-sky thinking | Nils Pratley
You’d think fund mangers would have deployed degree of scepticism after years of overvalued businesses
Nils Pratley
07, Dec, 2022 @7:18 PM
GSK shares surge as US judge dismisses Zantac cancer claims
About 50,000 federal lawsuits claimed that the best-selling heartburn drug had led to cancer
Joe Middleton and agencies
07, Dec, 2022 @3:40 PM
Mark Zuckerberg’s metaverse is a joke not shared equally with investors | Nils Pratley
Meta’s share price is down 73% in 2022 but Facebook investors can’t force the boss to change course
Nils Pratley
02, Nov, 2022 @6:50 PM
‘A better partner’: Labour woos big business in bid to oust Rishi Sunak
Wes Streeting and Jonathan Reynolds test water with pharma firm GSK as party prepares for election
Richard Partington
28, Oct, 2022 @3:51 PM
The only party not getting heartburn over GSK demerger is the lawyers | Nils Pratley
The depressing outcome of the split is a legal challenge in the US over Zantac that will run on for years
Nils Pratley
20, Sep, 2022 @6:04 PM
1 / 76 pages